Vitruvian Partners-backed KCAS completed the acquisition of Active Biomarkers.

Vitruvian Partners-backed KCAS, a company that provides comprehensive GLP compliant development services from early discovery support through product registration and beyond, completed the acquisition of Active Biomarkers, an integrated bioanalytical laboratory. Financial terms were not disclosed. “Our entire team is thrilled about the new partnership with KCAS and the combined organizations’ outlook. This combination will allow us to provide even more comprehensive, best-in-class services for the biopharma and life sciences sector. The KCAS’ alliance, backed by a leading world-class growth investor, will provide us with the support and growth to expand our technological expertise, capacity, and geographical footprint,” Marc Essodaigui, Active Biomarkers CEO.